mklives

SUNPHARMA.. bullish?

Long
mklives Mis à jour   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
SUNPHARMA after a long time, is crossing 200 dma
news about the whistle blower went in favour of the company
can be a contrarion bet in a weak market
above 441 close, can give 10 % returns possibly.
Commentaire:
sun pharma breaks above 200 dma which is good.. rsi above 60.
buy on dips to 441 and targets of 485 as first target. weekly rsi has double bottomed. looks like 500 can be tested but is a strong resistance since it is 100 weekly dma

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.